ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Meta-analysis"

  • 2019 American Transplant Congress

    Effects of Proton Pump Inhibitors on Allograft Rejection and Adverse Effects in Kidney Transplant Recipients: A Systemic Review and Meta-Analysis

    B. Boonpheng1, C. Thongprayoon2, M. A. Mao3, W. Cheungpasitporn4

    1Internal Medicine, East Tennessee State University, Johnson City, TN, TN, 2Nephrology, Mayo Clinic, Rochester, MN, MN, 3Nephrology, Mayo Clinic, Rochester, MN, 4Internal Medicine, University of Mississippi Medical Center, Jackson, MI, MS

    *Purpose: The adverse renal effects of proton pump inhibitors (PPIs) are being increasingly recognized in both the general population and chronic kidney disease patients. Several…
  • 2019 American Transplant Congress

    Caregiving in Thoracic Transplantation–A SR/MA

    A. A. Rmilah, J. Lau, R. Mendpara, P. Erwin, C. C. Kennedy

    Mayo Clinic, Rochester, MN

    *Purpose: Caregivers are required for heart and lung transplantation, however, little emphasis is placed on the pre-transplant caregiving experience. Our objective was to perform a…
  • 2018 American Transplant Congress

    Precision (re)Phenotyping of Histologically Stable Kidney Transplants

    D. Rychkov,1 T. Sigdel,2 M. Sirota,1 M. Sarwal.2

    1Institute for Computational Health Sciences, UCSF, San Francisco, CA; 2Department of Surgery, UCSF, San Francisco, CA.

    Background: Acute Rejection (AR) is the main cause of the renal failure within one year after transplantation (tx). Its earlier diagnosis is crucial for a…
  • 2018 American Transplant Congress

    The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis

    S. Wan,1,2 T. Ying,1,2 K. Wyburn,1,2 D. Roberts,3,4 M. Wyld,1,2 S. Chadban.1,2

    1Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; 2Sydney Medical School, University of Sydney, Sydney, Australia; 3Department of Renal Medicine, Canberra Hospital and Health Services, Canberra, Australia; 4Medical School, Australian National University, Canberra, Australia.

    Introduction: Current treatment strategies for antibody-mediated rejection (AMR) in kidney transplantation are based on low quality data from a small number of controlled trials. Novel…
  • 2018 American Transplant Congress

    Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis

    M. Chen, X. Lin, B. Huang, X. He.

    Organ Transplant Center, Sun yat-sen University, Guangzhou, China.

    Background. Splenectomy is performed as strategy of modulating the portal vein pressure in most of portal hypertension patients with liver cirrhosis. In liver transplantation, researchers…
  • 2018 American Transplant Congress

    A Meta-Analysis for Induction Therapy of Kidney Transplantation: Comparison of Antithymocyte Globulin and Interleukin 2 Receptor Antagonist

    G. Chen, Z. Wu, C. Wang, X. Liu, C. Wang, L. Chen.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Objectives To compare the efficacy and safety of antithymocyte globulin (ATG) and interleukin 2 receptor antagonist (IL2Ra) in induction therapy of kidney transplantation.Method A literature…
  • 2018 American Transplant Congress

    The Efficacy and Safety of Rituximab as Induction Therapy in Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials

    X. Wang,1 J. Chen,2 X. Tu,2 Y. Qiu,1 T. Song,1 T. Lin.1

    1Department of Urology/Institute of Urology/Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; 2West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan Province, China.

    Objectives. This meta-analysis was undertaken to assess the efficacy and safety of rituximab as induction therapy in kidney transplantation.Methods. OVID, Embase, SCI, PubMed and EBSCO…
  • 2018 American Transplant Congress

    The Association between Transplant Glomerulopathy and Graft Outcomes among Patients Undergoing Kidney Transplantation: Results of a Meta-Analysis

    G. Kovács,1 G. Devercelli,2 Z. Vokó,1,3 T. Zelei,1 I. Hirji,2 P. Keown.4,5

    1Syreon Research Institute, Budapest, Hungary; 2Shire, Lexington, MA; 3Health Policy & Health Economics, Eötvös Loránd University, Budapest, Hungary; 4Syreon Corporation, Vancouver, BC, Canada; 5University of British Columbia, Vancouver, BC, Canada.

    Transplant glomerulopathy (TG) can lead to irreversible kidney damage. TG is recognized as a surrogate marker for poor outcomes, including graft failure and loss among…
  • 2017 American Transplant Congress

    CMV and BK Virus Infections in Kidney Transplant Recipients Receiving an mTORi-Based Regimen versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis.

    B. Tanios,1 S. Mallat,1 H. Itani,1 T. Lotfi,1 S. Gabardi,2 E. Akl,1 J. Azzi.2

    1Division of Nephrology, American University of Beirut Medical Center, Beirut, Lebanon; 2Renal Division, Harvard Medical School, Boston

    The objective of this systematic review is to compare the incidence of CMV and BK virus infections in kidney transplant recipients receiving an mTORi-based as…
  • 2016 American Transplant Congress

    Effect of Modifying Life Support Withdrawal Practices on Outcomes of Donation After Circulatory Death in Liver Transplantation: A Meta-Analysis.

    Y. Cao,1,2 S. Shahrestani,3 H. Chew,2,4 M. Crawford,5 P. Macdonald,1,2,4 J. Laurence,3,5,7 W. Hawthorne,3,6 K. Dhital,1,2,4 H. Pleass.3,5,6

    1Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; 2Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; 3Sydney Medical School, University of Sydney, Sydney, NSW, Australia; 4Cardiac Transplant Unit, St. Vincent's Hospital, Sydney, NSW, Australia; 5Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 6The Department of Surgery, Westmead Hospital, Sydney, NSW, Australia; 7Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

    Aim. Donor warm ischaemic time is identified as the main risk factor for poor outcomes in liver transplantation using donation after circulatory death (DCD) compared…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences